Docoh
Loading...

SESN Sesen Bio

News

Pro users get this 30m faster
Sesen Bio, Qilu Pharmaceutical Announce Enrollment Of First Patient In Clinical Trial For Vicineum In China
20 Jul 21
News, Legal
Sesen Bio (NASDAQ:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and its partner in Greater China, Qilu Pharmaceutical, announced
Sesen Bio Announces Positive Outcome From Late-Cycle FDA Meeting For Vicineum Application
14 Jul 21
Biotech, News, Penny Stocks, Health Care, Small Cap, FDA, General
Analyzing Sesen Bio's Unusual Options Activity
9 Jul 21
Options, Markets
On Friday, shares of Sesen Bio (NASDAQ:SESN) saw unusual options activity. After the option alert, the stock price moved up to $4.14.
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
30 Jun 21
Biotech, News, Penny Stocks, Offerings, Small Cap, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)
Cramer Shares His Thoughts On Sesen Bio, Marathon Oil, More
22 Jun 21
Penny Stocks, Small Cap, Media
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer with a long position in Sesen Bio Inc (NASDAQ: SESN) to take some off the table.
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
18 Jun 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories, Pre-Market Outlook, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17)
Stocks That Hit 52-Week Highs On Thursday
17 Jun 21
News, Intraday Update, Markets, Movers, Trading Ideas
This morning 94 companies set new 52-week highs.
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
15 Jun 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)
Stocks That Hit 52-Week Highs On Monday
14 Jun 21
News, Intraday Update, Markets, Movers, Trading Ideas
During Monday's morning session, 255 companies made new 52-week highs.
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
10 Jun 21
Biotech, News, Penny Stocks, Small Cap, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9)
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
9 Jun 21
Biotech, News, Penny Stocks, Health Care, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8)
Stocks That Hit 52-Week Highs On Tuesday
8 Jun 21
News, Intraday Update, Markets, Movers, Trading Ideas
Tuesday morning saw 244 companies set new 52-week highs.
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
8 Jun 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7)
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
3 Jun 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2)
Understanding Sesen Bio's Unusual Options Activity
2 Jun 21
Options, Markets
Shares of Sesen Bio (NASDAQ:SESN) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $3.65.
Stocks That Hit 52-Week Highs On Wednesday
2 Jun 21
News, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday morning, 261 companies achieved new highs for the year.
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
2 Jun 21
Biotech, News, Penny Stocks, Health Care, Small Cap, FDA, Pre-Market Outlook, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1)
Sesen Bio Reports Global Supply Partnership With Qilu Pharma; Co. Will Receive $2M Milestone Payment Upon Completion Of Technology Transfer
2 Jun 21
News, Contracts
Technology transfer to Qilu Pharmaceutical on track for completion in 2021 Sesen Bio to receive $2M milestone payment upon completion of technology transfer Sesen Bio (NASDAQ:SESN), a late-stage clinical
68 Biggest Movers From Yesterday
2 Jun 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Watching T2 Biosystems Shares; Traders Circulate Article 'Billionaire Israel Englander Bets on These 2 Penny Stocks' Mentioning Co And Sesen Bio
25 May 21
Movers, Trading Ideas
https://www.tipranks.com/news/article/billionaire-israel-englander-bets-on-these-2-penny-stocks/

Press releases

Pro users get this 30m faster
Sesen Bio Announces Significant Commercial Progress as the Company Approaches the Potential Approval and Launch of Vicineum™ in the US
26 Jul 21
Penny Stocks, Small Cap, Press Releases
Hiring of the US sales force is 97% complete and sales training has commenced 14 Key Opinion Leader (KOL) speakers have been identified and speaker training has commenced
Sesen Bio Announces New Appointments to its Board of Directors
21 Jul 21
Penny Stocks, Small Cap, Press Releases
Peter K Honig, MD, MPH and Michael A.S. Jewett, MD, FRCSC, FACS have joined the Sesen Bio Board of Directors as the Company nears potential US approval of Vicineum™ in August 2021
Sesen Bio and Qilu Pharmaceutical Announce Enrollment of First Patient in Clinical Trial for Vicineum™ in China
20 Jul 21
Penny Stocks, Small Cap, Press Releases
Anticipated submission of product market application for Vicineum in China in 2022, with potential approval in 2023
Thinking about buying stock in Cytokinetics, Property Solutions Acquisition, Imara, ConforMIS, or Sesen Bio?
19 Jul 21
Opinion, Press Releases
NEW YORK, July 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CYTK, PSAC, IMRA, CFMS, and SESN.
Sesen Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 Jul 21
Penny Stocks, Small Cap, Press Releases
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported the grants of non-statutory stock options to four new employees in connection wit
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 Jun 21
Penny Stocks, Small Cap, Press Releases
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported the grant of a non-statutory stock option to one new employee in connection with
Thinking about buying stock in AMC, SRAX, Sesen Bio, Microvision, or PDS Biotechnology?
2 Jun 21
Opinion, Press Releases
NEW YORK, June 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, SRAX, SESN, MVIS, and PDSB.
Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical
2 Jun 21
Penny Stocks, Small Cap, Press Releases
Technology transfer to Qilu Pharmaceutical on track for completion in 2021 Sesen Bio to receive $2M milestone payment upon completion of technology transfer
Sesen Bio Strengthens Senior Leadership Team
1 Jun 21
Penny Stocks, Small Cap, Press Releases
Company hires four experienced leaders across commercial, medical and human resources functions as it works towards launch readiness
Sesen Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 May 21
Penny Stocks, Small Cap, Press Releases
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported the grant of a non-statutory stock option to one new employee in connection with the employee's commencement of employment wi
Sesen Bio Reports First Quarter 2021 Financial Results and Commercial Launch Readiness Update in the US for Vicineum™
10 May 21
Penny Stocks, Small Cap, Press Releases
Strengthened balance sheet with $110M in cash and cash equivalents as of March 31, 2021
Sesen Bio, Inc. to Host Earnings Call
10 May 21
Earnings, News, Press Releases
NEW YORK, NY / ACCESSWIRE / May 10, 2021 / Sesen Bio, Inc. (NASDAQ:SESN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 8:00 AM Eastern Time.To listen to